Vasoactive intestinal polypeptide

Details Vasoactive intestinal polypeptide Vasoactive intestinal polypeptide

A - Human Necessities

61

K

A61K 38/22 (2006.01) A61K 9/127 (2006.01)

Patent

CA 2187322

Provided is a method for delivering a vasoactive intestinal polypeptide (VIP) liposome product to a target tissue of a mammal. The VIP is expressed on and in a liposome. Also provided is a method of preparing the VIP liposome product comprising cholesterol, phosphatidyl choline, and phosphotidyl glycerol.

L'invention se rapporte à un procédé d'administration d'un liposome à polypeptide intestinal vasoactif (PIV) sur un tissu cible d'un mammifère. Le polypeptide intestinal vasoactif (PIV) est exprimé sur et dans un liposome. L'invention se rapporte à un procédé de préparation du liposome à PIV constitué de cholestérol, choline phosphatidyle et glycérol phosphotidyle.

Affiliated with

Also associated with

Rating

Vasoactive intestinal polypeptide does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vasoactive intestinal polypeptide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vasoactive intestinal polypeptide will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1587136